
Curlyfe Biosciences Private Limited
About Curlyfe Biosciences Private Limited
Data last updated:
Curlyfe Biosciences Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 May 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2022PTC398622.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prateek Mittal and Raghav Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 572 Sarita Vihar, Delhi, India – 110076.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.15 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.05 Cr (net margin -91%) and EBITDA of -₹1.04 Cr (EBITDA margin -90.6%).
Curlyfe Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0018971).
Company details
Recognitions & Rankings of Curlyfe Biosciences
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0018971
Contact details
Curlyfe Biosciences Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressF – 572 Sarita Vihar, Delhi, India – 110076
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Curlyfe Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curlyfe Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curlyfe Biosciences Private Limited, buy the company report.
Financials of Curlyfe Biosciences Private Limited
FY 2025 filings availableCurlyfe Biosciences Private Limited reported revenue of ₹1.15 Cr (up 235% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 235% in the latest year. EBITDA fell 47% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.04 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.05 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -90.6% | |
| Net Profit Margin | -91% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Curlyfe Biosciences Private Limited, buy the company report.
Board of directors of Curlyfe Biosciences Private Limited
Curlyfe Biosciences has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prateek Mittal Also directs: O P Mittal Industries Limited | Director | 19 May 2022 | 4 Years 5 Months | Current |
| Raghav Mittal Also directs: O P Mittal Industries Limited | Director | 19 May 2022 | 4 Years 5 Months | Current |
| Kamal Kumar Mittal Also directs: O P M Realtors LLP, O P Mittal Industries Limited | Director | 19 May 2022 | 4 Years 5 Months | Current |
| Pranav Mittal Also directs: O P Mittal Industries Limited | Director | 19 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Curlyfe Biosciences Private Limited is compared with the 4 companies closest to it by revenue in the Biotechnology industry (Biosciences), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Plug N Play Biosciences Private Limited | ₹1.24 Cr (FY 2025) | 126.0% | Navi Mumbai, Maharashtra, India | |||
| Saanvi Biosciences Private Limited | ₹1.19 Cr (FY 2024) | 6.0% | New Delhi, Delhi, India | |||
| Curlyfe Biosciences Private Limitedthis company | ₹1.15 Cr (FY 2024) | -₹1.05 Cr | -91% | 235.0% | Delhi, India | |
| Pinklabs Biosciences Private Limited | ₹1.15 Cr (FY 2025) | 26.0% | New Delhi, Delhi, India | |||
| Stem Biosciences Private Limited | ₹1.09 Cr (FY 2025) | 318.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Curlyfe Biosciences Private Limited, buy the company report.
Auditor
Curlyfe Biosciences Private Limited is audited by VSVG & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VSVG & Co. | FY 2023 | 005100N |
Legal cases
No court or tribunal cases involving Curlyfe Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curlyfe Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Curlyfe Biosciences Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
No GST registration is on our record for Curlyfe Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Curlyfe Biosciences Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Kamal Kumar Mittal was appointed as Director on 19 May 2022.
Frequently asked questions
Curlyfe Biosciences is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 May 2022 (4+ years old) and is registered under CIN U24239DL2022PTC398622.
Curlyfe Biosciences has 4 current directors:
- Prateek Mittal - Director
- Raghav Mittal - Director
- Kamal Kumar Mittal - Director
- Pranav Mittal - Director
The latest financial statements of Curlyfe Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Curlyfe Biosciences is U24239DL2022PTC398622. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curlyfe Biosciences was incorporated on 19 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Curlyfe Biosciences by revenue are Plug N Play Biosciences Private Limited, Saanvi Biosciences Private Limited, Pinklabs Biosciences Private Limited, Stem Biosciences Private Limited, all in the Biotechnology industry (Biosciences), with the same principal business activity (wholesale trading).
Kamal Kumar Mittal was appointed as Director on 19 May 2022. Pranav Mittal was appointed as Director on 19 May 2022. Prateek Mittal was appointed as Director on 19 May 2022. Curlyfe Biosciences has 4 board changes on record in total.
Yes, Curlyfe Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Curlyfe Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0018971).
The registered office of Curlyfe Biosciences is at F – 572 Sarita Vihar, Delhi, India – 110076.
Curlyfe Biosciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

